News

Acuvue Oasys for astigmatism combines the accelerated stabilization design (ASD) technology of Acuvue Advance brand contact lenses for astigmatism, with senofilcon A, the new generation silicone hydrogel material

Dr Ramachandra succeeds Edward Ogunro who retired on December 31, 2007, and will report directly to Christopher Begley, chairman and CEO. Most recently, Dr Ramachandra served as vice

The co-operative research and development agreement, initiated in March 2006, was extended through September 2009. John Kovach, president and CEO of Lixte, said: “The scientific interaction with the

This new E100 million facility, located in Val de Reuil (North West of France), incorporates the latest technology to produce vaccines that meet the highest standards of quality.

The interim results represent data from the first 80 patients enrolled in the targeted 100-patient clinical trial. Approximately 30 healthy subjects were enrolled to evaluate the efficacy of

These additional results demonstrated that once-daily dosing with the enteric-coated tablet formulation of RDEA806 resulted in significant reductions in plasma viral load that were consistent with results previously

The payments were triggered when Osiris accomplished certain clinical and regulatory milestones including initiating patient treatments. Jay Skyler, professor of medicine and associate director of the Diabetes Research

Located in the Chao Yang District of Beijing, the office will be headed by Aileen Ren, vice general manager of sales and marketing for Cynosure China, the company’s

The agency issued the letter to advice that it has completed its review of the submission and that there are issues that preclude approval of the supplement within